— Fundamental Stock Analysis and Report Card
Located in Allentown, PA, US. Operating globally, Air Products and Chemicals, Inc. (APD) is a prominent supplier of industrial gases, specialized equipment, and associated services. The company's diverse product range includes atmospheric gases such as oxygen, nitrogen, and argon, as well as various process gases like hydrogen, helium, carbon dioxide, carbon monoxide, and syngas. They also provide a selection of specialty gases. APD is involved in the fabrication of crucial machinery for gas production and handling, including air separation units and non-cryogenic generators. These products and services cater to a broad spectrum of industries, including but not limited to refining, chemical processing, gasification, metals production, general manufacturing, food and beverage, electronics, medical imaging, and energy generation. Moreover, the company's capabilities extend to designing and manufacturing advanced systems for air separation, hydrocarbon recovery and purification, the liquefaction of natural gas, and the secure transportation and storage of liquid helium and hydrogen. APD also engages in a strategic partnership with Baker Hughes Company to further innovate hydrogen compression systems. The firm was established in 1940 and is based in Allentown, Pennsylvania.
Revenue, earnings and profitability.
Strong revenue growth and earnings can attract investors, driving the stock price up. Profitability indicates the company's efficiency and sustainability, which impacts investor confidence. Poor performance in these areas can lead to a decrease in stock price.
Revenue History
Earnings History
Margins
Income & Cash Flow analysis.
An income statement shows what a company earned and spent over a period — revenue at the top, costs and expenses in between, and net income at the bottom. A cash flow statement tracks the actual cash moving in and out, across operations, investing, and financing. Read together, they show whether reported earnings are backed by real cash.
Q2 2026 Total ($) | Q2 2026 Margin (%) | |
|---|---|---|
| Revenue | 3.2b +255.6m +8.8% | |
| Gross Income | 987.4m +125.1m +14.5% | 31% +1.6pp +5.3% |
| EBITDA | 1.3b +3.1b +172.0% | 41% +103.6pp +166.2% |
| Operating Income | 752.7m +3.1b +132.3% | 24% +103.6pp +129.7% |
| Net Income | 710.4m +2.4b +141.0% | 22% +81.7pp +137.7% |
| Earnings Per Share | 3.19 +11.0 +141.1% | |
| Operating Cash Flow | 1.1b +775.6m +236.4% | 35% +23.5pp +209.3% |
| Free Cash Flow | 2.4b +3.9b +250.6% | 74% +127.9pp +238.5% |
| Research & Development | 21.6m -1.3m -5.7% | 1% -0.1pp -13.3% |
What are the analysts saying?
Analyst Consensus aggregates Wall Street recommendations into buy/hold/sell counts, while the Fundamental Scorecard grades the company on six financial ratios (P/B, P/E, D/E, ROA, ROE, DCF) plus an overall score. The two measure different things and can point in different directions.